Abstract

Ruthenium-106 (106Ru) plaques are specific applicators dedicated for intraocular brachytherapy. Small tumor volume and presence of vital organs in its close vicinity as well as appearance of very high dose gradient regions around the employed plaques cause unique challenges in plaque-based brachytherapy. Therefore, access to 3D dose distribution for each brachytherapy plaque is quite helpful to decide about tumor volume coverage and overexposure of surrounding sensitive organs. Current study aims to measure the 3D dose distribution for two commercially available 106Ru plaques using film dosimetry.COB (a notched-shape plaque) and CGD (a fully circular plaque) 106Ru plaques were used and dose distributions in different planes were measured by simultaneously employing a 3D printed eyeball phantom and Gafchromic EBT3 films. Finally, 3D dose distributions were acquired by interpolating the measured 2D dose data at different planes.The results showed that employing the COB plaque tilts the isodose curves toward the non-notched edge of the plaque, while no isodose tilting was observed for CGD plaque. The obtained 3D dose distributions were different for studied plaques. Non-uniform 3D dose distributions were found for both plaques which can be attributed to the plaque design and reference point position on plaque central axis.Finally, it can be concluded that the obtained 3D dose distributions can specify the optimal tumor shape which can be adequately covered by brachytherapy plaque with minimizing the dose non-uniformity and hot point formation inside the treated volume. Obtained 3D dose distribution for each plaque can be employed for patient treatment planning.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call